{
    "nctId": "NCT06217874",
    "briefTitle": "Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast Cancer",
    "officialTitle": "Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast Cancer",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Carcinoma, Metastatic Breast Carcinoma, Recurrent Breast Carcinoma",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 5000,
    "primaryOutcomeMeasure": "Response to targeted therapies",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female participants must have histologically or cytologically confirmed invasive breast cancer.\n* Male participants must have biopsy proven breast cancer.\n* Age must be \\>= 18 years, and all must be able to understand and willing to sign an informed consent document.\n\nExclusion Criteria:\n\n* Dementia, altered mental status, or any psychiatric condition that would prohibit the understanding or rendering of informed consent; a history of serious or life-threatening allergic reaction to local anesthetics (i.e. lidocaine, xylocaine).\n* Any other condition, which in the opinion of the patient's treating oncologist, or the physician performing the biopsy procedure, would make participation in this protocol unreasonably hazardous for the patient.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}